Literature DB >> 26541061

The differentially methylated region of MEG8 is hypermethylated in patients with Temple syndrome.

Susanne Bens1, Julia Kolarova1, Gabriele Gillessen-Kaesbach2, Karin Buiting3, Jasmin Beygo3, Almuth Caliebe1, Ole Ammerpohl1, Reiner Siebert1.   

Abstract

AIM: To investigate the DNA-methylation levels in the newly described MEG8 differentially methylated region (DMR) in the imprinted cluster in 14q32 in patients with Temple syndrome. PATIENTS &
METHODS: We included three patients with Temple syndrome which were studied by Infinium HumanMethylation450 BeadChips, locus-specific bisulfite-pyrosequencing, methylation-specific-MLPA and microsatellite analyses. The tag-CpG of the MEG8-DMR was investigated using the Infinium HumanMethylation450 BeadChip.
RESULTS: In all three patients, the identical pattern of DNA-hypermethylation of the MEG8-DMR was observed along with DNA-hypomethylation of the IG-DMR and MEG3-DMR.
CONCLUSION: Based on the observed MEG8-DMR DNA-hypermethylation and previously published data, we conclude that DNA-methylation of the MEG3- and MEG8-DMR is functionally dependent on the DNA-methylation pattern of the IG-DMR. The observed combination of epimutations is predicted to be associated with bi-allelic MEG3 and MEG8 expression in individuals with Temple syndrome.

Entities:  

Keywords:  DNA methylation; IG-DMR; MEG3; MEG3-DMR; MEG8; MEG8-DMR; Temple syndrome; imprinting

Mesh:

Substances:

Year:  2015        PMID: 26541061     DOI: 10.2217/epi.15.73

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  7 in total

1.  New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome.

Authors:  Jasmin Beygo; Alma Küchler; Gabriele Gillessen-Kaesbach; Beate Albrecht; Jonas Eckle; Thomas Eggermann; Alexandra Gellhaus; Deniz Kanber; Ulrike Kordaß; Hermann-Josef Lüdecke; Sabine Purmann; Eva Rossier; Johannes van de Nes; Ilse M van der Werf; Maren Wenzel; Dagmar Wieczorek; Bernhard Horsthemke; Karin Buiting
Journal:  Eur J Hum Genet       Date:  2017-06-21       Impact factor: 4.246

2.  The origin of imprinting defects in Temple syndrome and comparison with other imprinting disorders.

Authors:  Jasmin Beygo; Claudia Mertel; Sabine Kaya; Gabriele Gillessen-Kaesbach; Thomas Eggermann; Bernhard Horsthemke; Karin Buiting
Journal:  Epigenetics       Date:  2018-09-19       Impact factor: 4.528

3.  ZNF445: a homozygous truncating variant in a patient with Temple syndrome and multilocus imprinting disturbance.

Authors:  Masayo Kagami; Kaori Hara-Isono; Keiko Matsubara; Kazuhiko Nakabayashi; Satoshi Narumi; Maki Fukami; Yumiko Ohkubo; Hirotomo Saitsu; Shuji Takada; Tsutomu Ogata
Journal:  Clin Epigenetics       Date:  2021-05-26       Impact factor: 6.551

4.  Genome-wide multilocus imprinting disturbance analysis in Temple syndrome and Kagami-Ogata syndrome.

Authors:  Masayo Kagami; Keiko Matsubara; Kazuhiko Nakabayashi; Akie Nakamura; Shinichiro Sano; Kohji Okamura; Kenichiro Hata; Maki Fukami; Tsutomu Ogata
Journal:  Genet Med       Date:  2016-09-15       Impact factor: 8.822

Review 5.  A review on the role of MEG8 lncRNA in human disorders.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Seyedpouzhia Shojaei
Journal:  Cancer Cell Int       Date:  2022-09-16       Impact factor: 6.429

6.  Identification of genes directly responding to DLK1 signaling in Callipyge sheep.

Authors:  Hui Yu; Jolena N Waddell; Shihuan Kuang; Ross L Tellam; Noelle E Cockett; Christopher A Bidwell
Journal:  BMC Genomics       Date:  2018-04-24       Impact factor: 3.969

Review 7.  Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors.

Authors:  Lilla Krokker; Attila Patócs; Henriett Butz
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.